IBEX LTD (IBEX) Stock Fundamental Analysis
NASDAQ:IBEX • BMG4690M1010
30.1 USD
+0.3 (+1.01%)
At close: Feb 13, 2026
30.1 USD
0 (0%)
After Hours: 2/13/2026, 8:15:55 PM
We assign a fundamental rating of 7 out of 10 to IBEX. IBEX was compared to 87 industry peers in the IT Services industry. IBEX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. IBEX is growing strongly while it also seems undervalued. This is an interesting combination With these ratings, IBEX could be worth investigating further for value and growth and quality investing!.
1. Profitability
1.1 Basic Checks
- IBEX had positive earnings in the past year.
- IBEX had a positive operating cash flow in the past year.
- IBEX had positive earnings in each of the past 5 years.
- In the past 5 years IBEX always reported a positive cash flow from operatings.
1.2 Ratios
- IBEX has a better Return On Assets (14.58%) than 93.10% of its industry peers.
- The Return On Equity of IBEX (28.81%) is better than 89.66% of its industry peers.
- IBEX's Return On Invested Capital of 21.63% is amongst the best of the industry. IBEX outperforms 95.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.58% | ||
| ROE | 28.81% | ||
| ROIC | 21.63% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a decent Profit Margin value of 7.14%, IBEX is doing good in the industry, outperforming 73.56% of the companies in the same industry.
- IBEX's Profit Margin has improved in the last couple of years.
- IBEX has a better Operating Margin (9.18%) than 67.82% of its industry peers.
- IBEX's Operating Margin has improved in the last couple of years.
- The Gross Margin of IBEX (30.62%) is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of IBEX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.18% | ||
| PM (TTM) | 7.14% | ||
| GM | 30.62% |
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IBEX is creating value.
- IBEX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- IBEX has an Altman-Z score of 4.85. This indicates that IBEX is financially healthy and has little risk of bankruptcy at the moment.
- IBEX's Altman-Z score of 4.85 is amongst the best of the industry. IBEX outperforms 80.46% of its industry peers.
- IBEX has a debt to FCF ratio of 0.05. This is a very positive value and a sign of high solvency as it would only need 0.05 years to pay back of all of its debts.
- IBEX has a better Debt to FCF ratio (0.05) than 91.95% of its industry peers.
- A Debt/Equity ratio of 0.01 indicates that IBEX is not too dependend on debt financing.
- IBEX has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. IBEX outperforms 83.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.05 | ||
| Altman-Z | 4.85 |
ROIC/WACC2.33
WACC9.29%
2.3 Liquidity
- IBEX has a Current Ratio of 1.82. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of IBEX (1.82) is comparable to the rest of the industry.
- A Quick Ratio of 1.82 indicates that IBEX should not have too much problems paying its short term obligations.
- The Quick ratio of IBEX (1.82) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.82 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 44.77% over the past year.
- Measured over the past years, IBEX shows a very strong growth in Earnings Per Share. The EPS has been growing by 41.04% on average per year.
- The Revenue has grown by 9.77% in the past year. This is quite good.
- The Revenue has been growing slightly by 6.62% on average over the past years.
EPS 1Y (TTM)44.77%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%47.46%
Revenue 1Y (TTM)9.77%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%16.73%
3.2 Future
- IBEX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.72% yearly.
- Based on estimates for the next years, IBEX will show a quite strong growth in Revenue. The Revenue will grow by 9.19% on average per year.
EPS Next Y22.95%
EPS Next 2Y13.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.81%
Revenue Next 2Y9.19%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 8.70, the valuation of IBEX can be described as very reasonable.
- Compared to the rest of the industry, the Price/Earnings ratio of IBEX indicates a rather cheap valuation: IBEX is cheaper than 88.51% of the companies listed in the same industry.
- IBEX is valuated cheaply when we compare the Price/Earnings ratio to 27.97, which is the current average of the S&P500 Index.
- IBEX is valuated reasonably with a Price/Forward Earnings ratio of 8.31.
- Based on the Price/Forward Earnings ratio, IBEX is valued cheaply inside the industry as 88.51% of the companies are valued more expensively.
- IBEX is valuated cheaply when we compare the Price/Forward Earnings ratio to 27.96, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.7 | ||
| Fwd PE | 8.31 |
4.2 Price Multiples
- IBEX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IBEX is cheaper than 90.80% of the companies in the same industry.
- 70.11% of the companies in the same industry are more expensive than IBEX, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.94 | ||
| EV/EBITDA | 5.37 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- The decent profitability rating of IBEX may justify a higher PE ratio.
- A more expensive valuation may be justified as IBEX's earnings are expected to grow with 13.72% in the coming years.
PEG (NY)0.38
PEG (5Y)0.21
EPS Next 2Y13.72%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- IBEX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
30.1
+0.3 (+1.01%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)02-05 2026-02-05/amc
Earnings (Next)05-06 2026-05-06/amc
Inst Owners94.08%
Inst Owner Change-0.01%
Ins Owners2.8%
Ins Owner Change0.29%
Market Cap403.64M
Revenue(TTM)558.27M
Net Income(TTM)41.38M
Analysts45.71
Price Target41.82 (38.94%)
Short Float %0.81%
Short Ratio1.09
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.95%
Min EPS beat(2)20.05%
Max EPS beat(2)21.85%
EPS beat(4)4
Avg EPS beat(4)16.83%
Min EPS beat(4)10.89%
Max EPS beat(4)21.85%
EPS beat(8)7
Avg EPS beat(8)12.58%
EPS beat(12)10
Avg EPS beat(12)14.59%
EPS beat(16)12
Avg EPS beat(16)13.3%
Revenue beat(2)2
Avg Revenue beat(2)5.51%
Min Revenue beat(2)2.5%
Max Revenue beat(2)8.52%
Revenue beat(4)4
Avg Revenue beat(4)4.65%
Min Revenue beat(4)2.45%
Max Revenue beat(4)8.52%
Revenue beat(8)5
Avg Revenue beat(8)1.79%
Revenue beat(12)5
Avg Revenue beat(12)-0.35%
Revenue beat(16)7
Avg Revenue beat(16)-0.06%
PT rev (1m)0%
PT rev (3m)6.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.48%
EPS NY rev (1m)0%
EPS NY rev (3m)5.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.82%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.7 | ||
| Fwd PE | 8.31 | ||
| P/S | 0.7 | ||
| P/FCF | 12.94 | ||
| P/OCF | 7.53 | ||
| P/B | 2.81 | ||
| P/tB | 3.06 | ||
| EV/EBITDA | 5.37 |
EPS(TTM)3.46
EY11.5%
EPS(NY)3.62
Fwd EY12.03%
FCF(TTM)2.33
FCFY7.73%
OCF(TTM)4
OCFY13.27%
SpS43.23
BVpS10.71
TBVpS9.83
PEG (NY)0.38
PEG (5Y)0.21
Graham Number28.88
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.58% | ||
| ROE | 28.81% | ||
| ROCE | 26.64% | ||
| ROIC | 21.63% | ||
| ROICexc | 24.4% | ||
| ROICexgc | 26.15% | ||
| OM | 9.18% | ||
| PM (TTM) | 7.14% | ||
| GM | 30.62% | ||
| FCFM | 5.38% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
F-Score8
Asset Turnover2.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.05 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | 129.83% | ||
| Cap/Sales | 3.86% | ||
| Interest Coverage | 31.53 | ||
| Cash Conversion | 76.01% | ||
| Profit Quality | 75.39% | ||
| Current Ratio | 1.82 | ||
| Quick Ratio | 1.82 | ||
| Altman-Z | 4.85 |
F-Score8
WACC9.29%
ROIC/WACC2.33
Cap/Depr(3y)83.97%
Cap/Depr(5y)108.52%
Cap/Sales(3y)2.89%
Cap/Sales(5y)3.72%
Profit Quality(3y)75.63%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.77%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%47.46%
EPS Next Y22.95%
EPS Next 2Y13.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.77%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%16.73%
Revenue Next Year12.81%
Revenue Next 2Y9.19%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y23.48%
EBIT growth 3Y33.16%
EBIT growth 5Y20.06%
EBIT Next Year68.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y13.26%
FCF growth 3Y24.66%
FCF growth 5Y-10.09%
OCF growth 1Y19.11%
OCF growth 3Y4.51%
OCF growth 5Y-2.46%
IBEX LTD / IBEX FAQ
Can you provide the ChartMill fundamental rating for IBEX LTD?
ChartMill assigns a fundamental rating of 7 / 10 to IBEX.
What is the valuation status for IBEX stock?
ChartMill assigns a valuation rating of 8 / 10 to IBEX LTD (IBEX). This can be considered as Undervalued.
What is the profitability of IBEX stock?
IBEX LTD (IBEX) has a profitability rating of 7 / 10.
What is the valuation of IBEX LTD based on its PE and PB ratios?
The Price/Earnings (PE) ratio for IBEX LTD (IBEX) is 8.7 and the Price/Book (PB) ratio is 2.81.
Is the dividend of IBEX LTD sustainable?
The dividend rating of IBEX LTD (IBEX) is 0 / 10 and the dividend payout ratio is 0%.